ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Cancer Programs Close Amid Gridlock

October 4, 2013

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

Study Finds Physician Referral By Centers Fraught With Problems, Potential Dangers

July 23, 1976

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009